SHC - NASDAQ

Sotera Health Company

SHC·NASDAQ

$15.27

+0.17%

HealthcareMedical - Diagnostics & Research

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.35B

EPS0.2700

P/E Ratio56.56

Earnings Date08/06/2026

3.26B

Assets

3Y+5.0%

5Y+18.0%

10Y+20.0%

2.66B

Total Liabilities

3Y-4.0%

5Y+15.0%

10Y-

606.03M

Total Equity

50%

3Y+73.0%

5Y+33.0%

10Y+1232.0%

Sotera Health Company Funding & Solvency Profile

SHC · NASDAQ

Current Assets

Cash & Cash Equivalents346.46M

Net Receivables176.27M

Inventory54.38M

Other Current Assets36.31M

Total Current Assets613 M

Non-Current Assets

Property, Plant & Equipment1.16B

Goodwill & Intangible Assets1.39B

Long-Term Investments0.00

Other Non-Current Assets94.36M

Total Non-Current Assets1 B

Total Assets

3.26B

Financial Health Analysis

Current Ratio

2.46x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

4.38x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

364 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

19% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

Sotera Health Company Balance Sheet

SHC • NASDAQ

Sotera Health Company Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	346.5M	277.2M	296.4M	395.2M	106.9M	102.4M	62.9M	96.3M
Cash & Short-Term Investments	346.5M	277.2M	296.4M	395.2M	106.9M	102.4M	62.9M	96.3M
Net Receivables	176.3M	165.8M	175.5M	155.7M	134M	131M	111.6M	141.6M
Accounts Receivables	139.3M	140.3M	147.7M	118.5M	108.2M	104.4M	88.6M	100M
Other Receivables	36.9M	25.5M	27.8M	37.2M	25.9M	26.6M	22.9M	41.6M
Inventory	54.4M	49.2M	48.3M	37.1M	54.3M	34.1M	37.4M	37.6M
Prepaids	0.0	17.2M	16.1M	40.4M	39.5M	36.7M	29.7M	25.2M
Other Current Assets	36.3M	16.6M	20.9M	16.6M	11.2M	10.7M	10.8M	12.2M
Total Current Assets	613.4M	526M	557.2M	645M	346M	315M	252.4M	312.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.2B	1.1B	971M	801M	690.7M	655.8M	582M	586.4M
Goodwill	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1B	1B
Intangible Assets	288.2M	317.7M	416.3M	491.3M	598.8M	643.4M	696M	766.1M
Goodwill & Intangible Assets	1.4B	1.4B	1.5B	1.6B	1.7B	1.8B	1.7B	1.8B
Long-Term Investments	0.0	0.0	0.0	0.0	9.4M	13.5M	0.0	0.0
Tax Assets	0.0	2.9M	5M	4.1M	5.9M	8.4M	2.3M	15.8M
Other Non-Current Assets	94.4M	79.6M	69.7M	74.6M	18.3M	9.3M	12.2M	4.2M
Total Non-Current Assets	2.6B	2.5B	2.6B	2.5B	2.4B	2.4B	2.3B	2.4B
Total Assets	3.3B	3.1B	3.1B	3.1B	2.8B	2.8B	2.6B	2.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	83.7M	66.6M	77.6M	82.6M	81.8M	65.4M	44.4M	49M
Accounts Payable	78M	55.1M	71M	74.1M	72.9M	52.4M	42M	46.4M
Other Payables	5.7M	11.5M	6.6M	8.4M	8.9M	13M	2.4M	2.7M
Accrued Expenses	0.0	45.4M	83.1M	447.3M	23.1M	19.7M	21M	22.4M
Short Term Debt	14M	14.8M	4.8M	197.1M	0.0	0.0	16.3M	15.3M
Capital Lease Obligations (Current)	9.2M	8M	14.7M	9.3M	10.4M	10.6M	1.3M	1.4M
Tax Payables	0.0	11.5M	6.6M	8.4M	8.9M	13M	2.4M	2.7M
Deferred Revenue	0.0	15.1M	13.5M	12.1M	8.7M	6.1M	3.6M	4.6M
Other Current Liabilities	142.7M	41.1M	36.9M	43.1M	37.2M	38.8M	37.3M	50.6M
Total Current Liabilities	249.6M	191M	230.7M	791.6M	161.2M	140.6M	124M	143.4M
NON-CURRENT LIABILITIES
Long Term Debt	2.1B	2.2B	2.2B	1.7B	1.7B	1.8B	2.8B	2.2B
Deferred Revenue (Non-Current)	17.1M	16.8M	18.8M	18.9M	20.7M	21.3M	21.4M	21M
Deferred Tax Liabilities (Non-Current)	71.1M	69.5M	64.5M	68M	134.5M	121.8M	137.2M	171.5M
Other Non-Current Liabilities	69M	61.6M	65.3M	63.3M	69.6M	124.4M	108.5M	106.2M
Total Non-Current Liabilities	2.4B	2.5B	2.5B	2B	2B	2.2B	3.1B	2.5B
Capital Lease Obligations	133M	127.7M	98.6M	87.8M	84.3M	84.4M	31.2M	32.9M
Total Liabilities	2.7B	2.7B	2.7B	2.8B	2.2B	2.3B	3.2B	2.7B
SHAREHOLDERS' EQUITY
Treasury Stock	-17M	-23.4M	-27.2M	-29.8M	-33.5M	-34M	0.0	0.0
Common Stock	2.9M	2.9M	2.9M	2.9M	2.9M	2.9M	2.3M	2.3M
Additional Paid-In Capital	1.3B	1.2B	1.2B	1.2B	1.2B	1.2B	0.0	162.4M
Retained Earnings	-532.1M	-610M	-654.4M	-705.8M	-472.2M	-589.1M	-550.5M	-10.4M
Accumulated Other Comprehensive Income/Loss	-109.8M	-208.3M	-92.7M	-106.7M	-83.6M	-93.8M	-94.4M	-110M
Total Stockholders' Equity	606M	404.9M	443.7M	350.2M	586.1M	452.3M	-642.6M	44.4M
Total Equity	606M	404.9M	443.7M	350.2M	586.1M	454.6M	-641.1M	45.5M
Minority Interest	0.0	0.0	0.0	0.0	0.0	2.3M	1.4M	1.1M
SUMMARY
Total Liabilities & Equity	3.3B	3.1B	3.1B	3.1B	2.8B	2.8B	2.6B	2.7B
Total Investments	0.0	0.0	0.0	0.0	9.4M	13.5M	0.0	0.0
Total Debt	2.3B	2.4B	2.3B	2B	1.8B	1.9B	2.8B	2.2B
Net Debt	1.9B	2.1B	2B	1.6B	1.7B	1.8B	2.8B	2.1B
Shares Outstanding	284,093,929	284,093,929	284,093,929	284,093,929	284,093,929	284,093,929	284,093,929	284,093,929

SEC Filings

SHC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 20, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 11, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 08, 2026	May 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 16, 2026	March 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 06, 2026	March 04, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 18, 2026	2026	View Filing

Showing 1 to 10 of 110 filings

Related Guides

Blog Categories

Continue your SHC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.